Plus Therapeutics, Inc.
PSTV
$0.59
$0.00-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.42M | 5.15M | -17.40M | -3.90M | -2.87M |
| Total Depreciation and Amortization | 77.00K | 77.00K | 146.00K | 103.00K | 199.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 539.00K | -6.52M | 12.52M | 216.00K | -849.00K |
| Change in Net Operating Assets | 1.26M | -4.50M | -1.44M | 2.37M | -156.00K |
| Cash from Operations | -2.55M | -5.80M | -6.17M | -1.21M | -3.68M |
| Capital Expenditure | -27.00K | -7.00K | -3.00K | -11.00K | -14.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 30.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.32M | -4.63M | 3.53M | 75.00K | 5.00K |
| Cash from Investing | 1.30M | -4.63M | 3.56M | 64.00K | -9.00K |
| Total Debt Issued | 0.00 | 0.00 | 3.74M | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -7.00M | 0.00 | 0.00 |
| Issuance of Common Stock | 16.86M | 3.02M | 15.66M | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -45.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.55M | -220.00K | -- | -- | 45.00K |
| Cash from Financing | 12.31M | 2.80M | 12.41M | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.06M | -7.63M | 9.79M | -1.15M | -3.69M |